ATE291437T1 - Verwendung von botulinustoxin zur gewinnung eines produkts für die verwendung bei gelenkerkrankungen, insbesondere hüftgelenkarthrose, epicondylitis und rotatorkappenerkrankungen - Google Patents

Verwendung von botulinustoxin zur gewinnung eines produkts für die verwendung bei gelenkerkrankungen, insbesondere hüftgelenkarthrose, epicondylitis und rotatorkappenerkrankungen

Info

Publication number
ATE291437T1
ATE291437T1 AT02727002T AT02727002T ATE291437T1 AT E291437 T1 ATE291437 T1 AT E291437T1 AT 02727002 T AT02727002 T AT 02727002T AT 02727002 T AT02727002 T AT 02727002T AT E291437 T1 ATE291437 T1 AT E291437T1
Authority
AT
Austria
Prior art keywords
epicondylitis
disease
product
joint diseases
botulinus toxin
Prior art date
Application number
AT02727002T
Other languages
English (en)
Inventor
Corrado Marchini
Fabiano Pinat
Fabio Pinat
Francesca Zecchini
Original Assignee
Univ Degli Studi Udine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11460457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE291437(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Degli Studi Udine filed Critical Univ Degli Studi Udine
Application granted granted Critical
Publication of ATE291437T1 publication Critical patent/ATE291437T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT02727002T 2001-01-05 2002-01-04 Verwendung von botulinustoxin zur gewinnung eines produkts für die verwendung bei gelenkerkrankungen, insbesondere hüftgelenkarthrose, epicondylitis und rotatorkappenerkrankungen ATE291437T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001UD000002A ITUD20010002A1 (it) 2001-01-05 2001-01-05 Uso della tossina botulinica per la soluzione di patologie articolari, in particolare della coxartrosi, della epicondilite e della patolo
PCT/IB2002/000003 WO2002053175A2 (en) 2001-01-05 2002-01-04 Use of botulinum toxin for treatment of articular pathologies

Publications (1)

Publication Number Publication Date
ATE291437T1 true ATE291437T1 (de) 2005-04-15

Family

ID=11460457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02727002T ATE291437T1 (de) 2001-01-05 2002-01-04 Verwendung von botulinustoxin zur gewinnung eines produkts für die verwendung bei gelenkerkrankungen, insbesondere hüftgelenkarthrose, epicondylitis und rotatorkappenerkrankungen

Country Status (15)

Country Link
US (2) US7208166B2 (de)
EP (1) EP1357937B1 (de)
JP (1) JP2004517114A (de)
CN (1) CN1318089C (de)
AT (1) ATE291437T1 (de)
AU (1) AU2002222432B8 (de)
CA (1) CA2433765C (de)
CY (1) CY1105490T1 (de)
DE (1) DE60203370T2 (de)
DK (1) DK1357937T3 (de)
ES (1) ES2242858T3 (de)
IT (1) ITUD20010002A1 (de)
PT (1) PT1357937E (de)
RU (1) RU2283664C2 (de)
WO (1) WO2002053175A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003009897A (ja) * 2001-07-03 2003-01-14 Keiji Oguma ボツリヌス毒素の分離・精製法
US7691394B2 (en) * 2002-05-28 2010-04-06 Botulinum Toxin Research Associates, Inc. High-potency botulinum toxin formulations
ATE426408T1 (de) * 2002-12-20 2009-04-15 Botulinum Toxin Res Ass Inc Pharmazeutische zusammensetzungen enthaltend botulinumtoxin und humanes serum-albumin
CA2576506A1 (en) * 2004-08-03 2006-02-16 Wagerworks, Inc. Gaming method and device involving progressive wagers
US8323666B2 (en) * 2005-08-01 2012-12-04 Allergan, Inc. Botulinum toxin compositions
EP2364168A1 (de) 2008-12-04 2011-09-14 Botulinum Toxin Research Associates, Inc. Verlängerte botulinustoxin-formulierung zur anwendung bei menschen oder säugetieren
US9393291B2 (en) 2012-04-12 2016-07-19 Botulinum Toxin Research Associates, Inc. Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds
RU2496150C1 (ru) * 2012-04-16 2013-10-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный университет им. Ф.М. Достоевского" Способ моделирования костной кристаллизации при коксартрозе in vitro
US9492513B2 (en) * 2013-04-25 2016-11-15 Allergan, Inc. Methods for treatment of hip and groin pain associated with femoroacetabular impingement (FAI)
US9901627B2 (en) 2014-07-18 2018-02-27 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease
US11484580B2 (en) 2014-07-18 2022-11-01 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease
CN105567739B (zh) * 2016-02-04 2019-07-12 郑州可尔利尔生物科技有限公司 病毒载体颗粒及其构建方法和应用
IL265109B2 (en) 2016-09-13 2024-05-01 Allergan Inc Stabilized non-protein clostridial toxin compositions
GB201815844D0 (en) * 2018-09-28 2018-11-14 Ipsen Biopharm Ltd Therapeutic & comestic uses of botulinum neurotoxin serotype e

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
RU2112446C1 (ru) * 1992-11-05 1998-06-10 Дагестанский государственный медицинский институт Способ лечения болезни пертеса
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
EP1488803B1 (de) 1993-12-28 2008-03-26 Allergan, Inc. Neurotoxisches Komponente von Botulinumtoxinen zur Behandlung von zervikaler Dystonie
US5721215A (en) * 1996-03-20 1998-02-24 Allergan Injectable therapy for control of muscle spasms and pain related to muscle spasms
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
TW574036B (en) * 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin
US6464986B1 (en) * 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6423319B1 (en) * 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries

Also Published As

Publication number Publication date
ITUD20010002A1 (it) 2002-07-05
CA2433765A1 (en) 2002-07-11
AU2002222432B8 (en) 2006-04-27
DE60203370D1 (de) 2005-04-28
RU2003124186A (ru) 2005-01-10
US20070020294A1 (en) 2007-01-25
WO2002053175A3 (en) 2002-09-12
WO2002053175A2 (en) 2002-07-11
CN1491115A (zh) 2004-04-21
AU2002222432B2 (en) 2006-04-13
RU2283664C2 (ru) 2006-09-20
EP1357937A2 (de) 2003-11-05
CN1318089C (zh) 2007-05-30
CY1105490T1 (el) 2010-04-28
PT1357937E (pt) 2005-08-31
ES2242858T3 (es) 2005-11-16
DK1357937T3 (da) 2005-08-01
US7208166B2 (en) 2007-04-24
US20040071735A1 (en) 2004-04-15
DE60203370T2 (de) 2006-02-09
CA2433765C (en) 2008-10-28
JP2004517114A (ja) 2004-06-10
EP1357937B1 (de) 2005-03-23

Similar Documents

Publication Publication Date Title
DE60203370D1 (de) Verwendung von botulinustoxin zur gewinnung eines produkts für die verwendung bei gelenkerkrankungen, insbesondere hüftgelenkarthrose, epicondylitis und rotatorkappenerkrankungen
EP1064308A4 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
PT1303632E (pt) Oligossacarideos de galactomanano e processo para a sua preparacao bem como sua utilizacao
IL132293A0 (en) Use of lactoferin in the treatment of allergen induced disorders
ATE382053T1 (de) System zur antikörperexpression und- synthese
BR0313792A (pt) Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
ES2190653T3 (es) Productos de reaccion del acido hialuronico y de aminoacidos naturales y su utilizacion en composiciones cosmeticas y farmaceuticas.
PT1171143E (pt) Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto
PE110499A1 (es) Proceso para aislar una composicion proteica de una fuente muscular
BR0116356A (pt) Lente de contato com modelo de ìris opaco
ATE364393T1 (de) Verwendung eines botulinumtoxins zur herstellung eines arzneimittels zur peripheren behandlung von schmerzen, die nicht mit muskelspasmen oder kopfschmerzen in verbindung stehen
EP1578616A4 (de) Mehrteilige form mit abtrennbarem armband, abtrennbaren etiketten und karten oder dergleichen
AU305825S (en) Bottle
PT1404304E (pt) Comprimido contendo cetirizina e pseudoefedrina
MY129643A (en) Tablet comprising cetirizine and pseudoephedrine
DE60229867D1 (de) Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
DE69517191D1 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
BR0307341A (pt) Delta1-pirrolinas
WO1998031712A3 (en) Chitosan-conjugates with acidic chelate-complex forming agents
BR0106880A (pt) Tubulação metálica revestida com um polìmero termoplástico para o transporte de produtos de petróleo, e, processo para revestir uma tubulação metálica com uma camisa termoplástica
DE10084841T1 (de) Brikett, geeignet zur Verflüssigung von Hüttenschlacke, und die Brikett-Herstellungsmethode
FR2873698B1 (fr) Nouveau peptide et composition pharmaceutique le contenant
RU2003100975A (ru) Способ лечения повреждений дистального сухожилия двуглавой мышцы плеча
NZ514691A (en) Method to type prion proteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1357937

Country of ref document: EP

EEIH Change in the person of patent owner
RZN Patent revoked